Challenges in the Diagnosis of SARS-CoV-2 Infection in the Nervous System

• Published in: Viruses Vol. 16; no. 8; p. 1247
• Main Authors: Da Silva, Samya Jezine, Cabral-Castro, Mauro Jorge, Gonçalves, Cássia Cristina Alves, Mariani, Diana, Ferreira, Orlando, Tanuri, Amílcar, Puccioni-Sohler, Marzia
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.08.2024; MDPI
• Subjects: Accuracy; anti-SARS-CoV-2 immunoglobulins; Antibodies; Biomarkers; Cerebrospinal fluid; COVID-19; Diagnosis; Diagnostic tests; Disease; Encephalitis; Guillain-Barre syndrome; Health aspects; Immunoglobulin G; Immunoglobulin M; Infections; inflammatory biomarkers; Inflammatory diseases; Meningitis; Meningoencephalitis; Metabolism; molecular biomarkers; Neopterin; Nervous system; neuroCOVID-19; Pandemics; Patients; Polymerase chain reaction; Proteins; Ribonucleic acid; RNA; Severe acute respiratory syndrome coronavirus 2; γ-Interferon; Brazil; United States > US; Germany
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v16081247

Neurological involvement has been widely reported in SARS-CoV-2 infection. However, viral identification in the cerebrospinal fluid (CSF) is rarely found. The aim of this study is to evaluate the accuracy of virological and immunological biomarkers in CSF for the diagnosis of neuroCOVID-19. We analyzed 69 CSF samples from patients with neurological manifestations: 14 with suspected/confirmed COVID-19, with 5 additional serial CSF samples (group A), and as a control, 50 non-COVID-19 cases (group B—26 with other neuroinflammatory diseases; group C—24 with non-inflammatory diseases). Real-time reverse-transcription polymerase chain reaction (real-time RT-PCR) was used to determine SARS-CoV-2, and specific IgG, IgM, neopterin, and protein 10 induced by gamma interferon (CXCL-10) were evaluated in the CSF samples. No samples were amplified for SARS-CoV-2 by real-time RT-PCR. The sensitivity levels of anti-SARS-CoV-2 IgG and IgM were 50% and 14.28%, respectively, with 100% specificity for both tests. CXCL-10 showed high sensitivity (95.83%) and specificity (95.83%) for detection of neuroinflammation. Serial CSF analysis showed an association between the neuroinflammatory biomarkers and outcome (death and hospital discharge) in two cases (meningoencephalitis and rhombencephalitis). The detection of SARS-CoV-2 RNA and specific immunoglobulins in the CSF can be used for neuroCOVID-19 confirmation. Additionally, CXCL-10 in the CSF may contribute to the diagnosis and monitoring of neuroCOVID-19.